Responsive Nano-structured Cubosomes: Advancements and Therapeutic Applications.

Area of Science:

• Nanotechnology
• Materials Science
• Pharmaceutical Sciences

Background:

• Nanotechnology offers advanced drug delivery systems to maximize treatment efficacy and minimize side effects.
• Lyotropic liquid crystalline nanoparticles (LLCNP), including cubosomes and hexosomes, are gaining interest due to their unique molecular structures.
• Cubosomes can encapsulate various drug types (lipophilic, hydrophilic, amphiphilic), positioning them as versatile drug carriers.

Purpose of the Study:

• To review different types of cubosomes, including stimuli-responsive variants (pH, temperature, light, enzyme).
• To detail the preparation methods and therapeutic applications of these advanced cubosome formulations.
• To highlight the potential of cubosomes in targeted drug delivery, focusing on bioavailability and controlled release.

Main Methods:

• Review of existing literature on cubosome preparation and characterization.
• Analysis of different stimuli-responsive cubosome formulations.
• Evaluation of therapeutic applications and drug delivery performance of cubosomes.

Main Results:

• Cubosomes exhibit high surface area, biocompatibility, and enhanced drug protection.
• Various stimuli-responsive cubosomes (pH, temperature, light, enzyme) have been developed for tailored drug release.
• Cubosomes show potential for optimizing bioavailability and achieving controlled drug release for targeted delivery.

Conclusions:

• Cubosomes represent a promising nanotechnology for advanced drug delivery systems.
• Key challenges for cubosome formulation include stability and scalability.
• Further research into cubosomes can lead to optimized therapeutic outcomes and reduced side effects.